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Chemoselective synthesis and analysis of naturally
occurring phosphorylated cysteine peptides
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In contrast to protein O-phosphorylation, studying the function of the less frequent N- and
S-phosphorylation events have lagged behind because they have chemical features that
prevent their manipulation through standard synthetic and analytical methods. Here we
report on the development of a chemoselective synthetic method to phosphorylate Cys
side-chains in unprotected peptides. This approach makes use of a reaction between
nucleophilic phosphites and electrophilic disulﬁdes accessible by standard methods. We
achieve the stereochemically deﬁned phosphorylation of a Cys residue and verify the
modiﬁcation using electron-transfer higher-energy dissociation (EThcD) mass spectrometry.
To demonstrate the use of the approach in resolving biological questions, we identify an
endogenous Cys phosphorylation site in IICBGlc, which is known to be involved in the
carbohydrate uptake from the bacterial phosphotransferase system (PTS). This new chemical
and analytical approach ﬁnally allows further investigating the functions and signiﬁcance of
Cys phosphorylation in a wide range of crucial cellular processes.
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P
rotein phosphorylation is a major actor in the regulation of
biochemical signalling pathways and a wide range of other
essential cellular processes1,2. Extensive studies of phospho-
rylation, which mainly occurs on serine, threonine and tyrosine
amino-acid side chains, have revealed important insights into
protein functions. The phosphorylation of other amino acids,
such as phospho-histidine (pHis), -arginine (pArg), -lysine (pLys)
and -cysteine (pCys), is less understood and studies of these
events have been hindered by technical limitations3–7. The main
obstacle to studying N- and S-phosphorylation has been their
acid-lability, which prevents their accessibility and characteri-
zation through standard chemical and analytical tools.
Important steps have been recently made towards the
development of synthetic tools to allow the site-speciﬁc
phosphorylation of native pLys and pArg peptides and mimetics
of pHis in proteins8–13. These chemical tools have permitted the
development of mass spectrometry (MS)-based methods or the
generation of antibodies, leading to a better understanding of the
biological role of these modiﬁcations14–16. The isolation and
characterization of phosphorylated-Cys peptides, however, has
been challenging due to the acid-lability of the phosphorothiolate
bond, which has prevented further identiﬁcation of unknown
pCys sites using standard phosphoproteomic approaches7.
pCys is known to function as an intermediate in the phos-
phoenolpyruvate (PEP)-dependent phosphotransferase system
(PTS), in the dephosphorylation of phosphotyrosine residues by
protein tyrosine phosphatases, and in bacterial signalling and
regulation17–26. In addition to its natural biological functions,
pCys has recently been employed as a phosphoserine
and phosphothreonine mimetic27–29. In this work, Davis and
co-workers30 have developed a two-step method for installing
pCys residues on a protein level; however, this protocol delivers
an epimeric mixture of pCys proteins, since it relies on the
reaction of dehydroalanine (Dha) with sodium thiophosphate.
Although this elegant strategy provided access to pCys residues in
proteins, the elimination conditions required to prepare Dha
residues and the lack of stereoselectivity may impose certain
limitations on the general applicability of this chemical tool in the
functional analysis of phosphorylated Cys residues8.
In this report we develop a novel chemoselective and
stereochemically deﬁned phosphorylation strategy for Cys
residues (Fig. 1). As a key step in our strategy we envision to
exploit the nucleophilic reactivity of P(III)-reagents (phosphites)
with electrophilic disulﬁdes. Moreover, we develop a benign
MS-based proteomic approach to identify and characterize pCys
sites that naturally occur in peptides. Finally, we identify and
characterize an endogenous pCys peptide from the glucose-
speciﬁc transporter IICBGlc, which is known to be involved in the
PTS by following a MS-based proteomic approach using electron-
transfer higher-energy dissociation (EThcD) tandem MS. This
work provides a novel synthetic strategy to incorporate native
L-pCys residues into unprotected peptides, along with an
analytical method that unambiguously reveals phosphorylation
on Cys sites in native peptides.
Results
Synthesis of pCys peptides. To show the feasibility of this
chemical strategy, our initial experiments were carried out in
reactions with naturally occurring cystines using phosphite
triesters that had previously been synthesized by our laboratory
(3b-e) (refs 9,10). Our ﬁrst attempts to use oxidized glutathione
(GSSG) and commercially available trimethyl phosphite in
dimethylformamide (DMF) did not reveal a formation of a
corresponding phosphorothiolate ester. The reactivity of GSSG
towards phosphites was also tested in water (25mM Tris-HCl at
pH 8.0) using the water-soluble phosphite 3e, but once again
failed to exhibit a formation of phosphorothiolate esters.
Based on reports of previous work on the synthesis of
phosphoro-thioate and -thiolate nucleotides31–33, we decided to
test an electron-deﬁcient disulﬁde peptide for reactivity (Fig. 1).
Thereby, we take advantage of standard peptide synthesis
protocols to obtain electrophilic disulﬁdes 2 from Cys-
containing peptides 1 through the addition of 5,50-dithiobis-2-
nitrobenzoic acid (Ellman’s reagent). Subsequent reaction with
phosphites 3 delivers the corresponding phosphorothiolate ester
peptides 4, which yield pCys-peptides 6 after phosphodiester
cleavage. The use of electron-deﬁcient aryl disulﬁdes such
as 2,20-dithiobis(5-nitropyridine) and Ellman’s reagent have
been exploited to activate Cys thiols for subsequent ligation
with Cys-containing ubiquitin fragments and as precursors of
Dha residues upon elimination using phosphines or 1,8-diaza-
bicycloundec-7-ene (refs 34,35). To the best of our knowledge,
the chemoselectivity of P(III) reagents has not previously been
successfully exploited in reactions between different nucleophilic
phosphite esters and electrophilic disulﬁdes to form phos-
phorothiolate ester derivatives on a peptide level.
We ﬁrst synthesized a small Cys-containing peptide
(sequence LYRCAK) 1a using standard solid-phase peptide
synthesis (SPPS; Fig. 2a). Peptide 1a was then reacted with
Ellman’s reagent following standard protocols to form peptide
2a (Fig. 2a)35. With the isolated peptide 2a in hand, we ﬁrst
probed the reactivity with phosphites 3 in DMF (Fig. 2a,
Table 1). The reaction with tributyl phosphite (3a) and analysis
of the reaction crude by ultra performance liquid
chromatography-ultraviolet (UPLC-UV) coupled to MS
showed a formation of mainly Cys peptide 1a along with a
minor amount of phosphorothiolate ester peptide 4a (Table 1).
In contrast, the base-cleavable phosphite 3b revealed a good
conversion after isolation using semi-preparative high-
performance liquid chromatography (HPLC), yielding peptide
4b in 37% isolated yield (Table 1). However, the formation of
peptide 1a was also observed.
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Figure 1 | Synthetic strategy to install pCys residues in unprotected peptides. Site-selective addition of phosphite to an activated Ellman-disulﬁde to
deliver a stereochemically deﬁned pCys residue.
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Upon probing light-cleavable o-nitrobenzyl-based phosphites
3c–3e, the benzyl-substituted phosphite 3d showed an almost
complete conversion to phosphorothiolate ester peptide 4d, with
a minor formation of hydrolysis product 1a based on UPLC-UV-
MS, and in 55% isolated yield after semi-preparative HPLC
(Fig. 2a–c, Table 1). Interestingly, when using phosphites with no
substituent at the benzyl position such as 3c or 3e, we observed
formation of monoprotected phosphorothiolate ester 5 in
addition to the expected product 4 and peptide 1a (Table 1,
Supplementary Fig. 1). We reasoned that the formation of
monoprotected phosphorothiolate esters (5c, 5e) is due to a
nucleophilic attack on the electrophilic benzylic position of the
o-nitrobenzyl substrates by water or by the thiolate nitrobenzoic
acid by-product. As expected, when using phosphite 3d the
monoprotected ester 5d was not formed due to the decreased
reactivity of the benzylic position (Fig. 2b, Table 1).
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Figure 2 | Chemoselective synthesis of phosphorothiolate esters peptides 4 and 5. (a) Reaction of peptide 1a with Ellman’s reagent and peptide 2a with
5 eq. phosphite esters 3a–e. (b) Overlap of UPLC traces of reaction mixture for peptide 2a and phosphite 3d after 16 h (black) and phosphite 3d starting
material (magenta). Formation of the phosphorothiolate ester 4d after 16 h incubation with phosphite 3d in DMF at room temperature. Magenta asterisk
shows the by-products of the phosphite 3d decomposition, which overlap with the reaction mixture UPLC trace for peptide 2a and phosphite 3d.
(c) UPLC-UV trace after puriﬁcation by semi-preparative HPLC of phosphorothiolate ester 4d. a.u., arbitrary unit; r.t., room temperature.
Table 1 | MS-conversion and isolated yields for phosphorothiolate esters peptides 4 and 5.
Entry Phosphite* Solventw Product % Conversionz % Yieldy Product % Conversionz % Yieldy
1 3a DMF 4a 20 — 5a — —
2 3b DMF 4b 54 37 5b — —
3 3c DMF 4c 6 — 5c 32 —
4 3d DMF 4d 97 55 5d — —
5 3e DMF 4e 22 27 5e 35 34
6 3a MeCN:Tris (1:1) 4a 18 — 5a — —
7 3b MeCN:Tris (1:1) 4b 59 43 5b — —
8 3c MeCN:Tris (3:2) 4c 7 — 5c 18 —
9 3d MeCN:Tris (3:2) 4d 36 27 5d — —
10 3e Tris, pH 7.2 4e 2 — 5e 25 —
11 3e Tris, pH 8.0 4e 3 — 5e 30 38
*5 eq. of phosphite was used for each entry.
wMeCN:Tris mixtures consist on MeCN and 25mM Tris-HCl at pH 7.2.
zConversion was determined by LC–MS analysis after 2a was depleted. The sum of areas under the XIC peaks corresponding to 1a, 2a, oxidized 1a, 4 and 5, for each entry, were counted as a 100%. All
experiments were performed at least in duplicate, and the average values are presented.
yIsolated yields of 4b, 4d, 4e and 5e products after semi-preparative HPLC. For synthetic procedures see Supplementary Methods.
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Next, we investigated the reactivity in buffered aqueous
solvents. Reactions of peptide 2a with phosphites 3a and 3b in
a mixture of MeCN and 25mM Tris-HCl pH 7.2 yielded
conversions similar to those we had previously observed in DMF
(Table 1). In the case of phosphite 3d, we observed lower
conversion to the desired product 4d, which was isolated in 27%
yield (Table 1). Interestingly, MS-readouts showed an increase in
the formation of peptide 1a and its corresponding oxidized
disulﬁde product (Supplementary Figs 2 and 3). Using the water-
soluble phosphite 3e, the monoprotected phosphorothiolate ester
5e was obtained in good conversions, together with formation of
signiﬁcant amounts of hydrolysed peptide 1a (Table 1,
Supplementary Fig. 4). In general, we reasoned that formation
of peptide 1a might occur from the ﬁrst intermediate during the
reaction between phosphites and electrophilic disulﬁdes, that is,
the triester thiophosphonium cation. At this stage the P-S versus
P-O bond hydrolysis seems to depend heavily on the nucleophilic
substances in the reaction media and also on the nature of the
phosphorothiolate ester substituents that are used.
We used a small peptide sequence (YCA) with an L-Cys (1b) or
a D-Cys (1c) to demonstrate that our synthetic strategy is
epimerization-free. The disulﬁdes 2b and 2c reacted with
phosphite 3b to produce unique phosphorothiolate ester peptides,
4h and 4i, respectively (Supplementary Figs 5 and 6). Analysing
the reaction crudes for both phosphorylation reactions through
UPLC-UV and -MS revealed that 4h and 4i have different
retention times, which showed that our synthetic pathway does
not involve a Dha intermediate (Supplementary Fig. 7). We
obtained analogous results using phosphite 3a and 3d
(Supplementary Figs 8–13).
We then applied ultraviolet-irradiation or alkaline deprotection
conditions to peptides 4b, 4d and 4e to facilitate the formation of
native phosphorylated Cys peptides 6. Previously, o-nitrobenzyl
esters-type caged groups have been used to access pTyr
analogues, native pLys peptides, or phosphomonoesters through
mild light-induced photolysis9,36–38. The base-labile cyanoethyl
group is commonly used as protecting group in phosphorimidites
in a similar way for the solid-phase synthesis of oligonucleotides
and we have recently used it as a precursor of pLys peptides10,39.
The photodeprotection of peptide 4d and 4e upon exposure to
295 nm light for 5 and 15min, respectively, delivered
phosphorylated Cys peptide 6a, with minor formation of the
hydrolysed P-S bond by-product (Fig. 3a,b, Supplementary
Fig. 14). In contrast, incubating peptide 4b with 250mM
NaOH delivered a signiﬁcant amount of Dha-containing
peptide in addition to the phosphorylated Cys peptide 6a,
convincing us to abandon cyanoethyl-derivatives as protective
groups for the delivery of phosphorylated Cys-containing
peptides (Supplementary Fig. 15).
After we had successfully synthesized pCys peptide 6a, we
probed its stability at different pH values, using UPLC-UV and
-MS to follow its rate of decay. Acidic pH values decreased the
stability of the phosphorothiolate bond in pCys peptide 6a, as
expected, with a half-life of 3 h in either 0.1% formic acid
(FA, pH 2.9) or 0.1% triﬂuoroacetic acid (TFA, pH 2.0)
(Supplementary Fig. 16). In contrast, peptide 6a showed sufﬁcient
stability with minor hydrolysis both at pH 7.4 and 8.4 over a period
of 24 h (Supplementary Fig. 16). In order to avoid signiﬁcant
hydrolysis, pCys peptides should be puriﬁed by using a MeCN/
water gradient in alkaline aqueous buffer (pH 8.4) as a mobile
phase. Peptide 6a was isolated in 65% yield and with a purity
criteria Z90% based on UPLC-UV (Supplementary Fig. 17).
Analytical characterization of pCys peptides. Next, we char-
acterized the synthesized pCys peptide sequence 6a by NMR and
MS to conﬁrm the site-speciﬁc modiﬁcation of the peptide and to
rule out a phosphate-transfer or migration processes during their
synthesis. Using 31P-NMR, we observed a major signal at
12.02 p.p.m. (Fig. 3c), which is characteristic according to the
literature22,24. Additionally, a minor peak at  2.63 p.p.m. was
found which was attributed to inorganic phosphate by addition of
external sodium phosphate. To demonstrate that the 31P signal was
attached to a Cys residue, an 1H-31P HMBC NMR experiment was
performed. The phosphorous signal peak at 12.02 p.p.m. showed
coupling to the a-methylene hydrogen atoms in the pCys side-
chain at 3.13 p.p.m., conﬁrming that the phosphate was attached to
a Cys side chain (Supplementary Fig. 18). However, if peptide
sequences in biological samples had additional Cys residues, it
would be difﬁcult or impossible with NMR to determine which Cys
side chains had been phosphorylated.
We, therefore, turned to MS to unambiguously localize the
phosphorylation site in 6a. In addition, we intended to implement
a tandem MS (MS/MS) method, which would also facilitate the
assignment of Cys phosphorylation sites in proteomic analysis of
samples from biological origin40. MS/MS has become the method
of choice for analysis of post-translational modiﬁcations in
peptides; when coupled with nanoliquid chromatography (nLC),
the method provides high-sensitivity and can be implemented in
a high-throughput manner41. While collision-induced dissocia-
tion (CID) is the most common fragmentation technique for
synthetic peptides or enzymatically generated protein fragments,
its applicability to analyse peptides containing post-translational
modiﬁcations is in some cases problematic42. The superiority of
radical-driven fragmentation techniques such as electron-capture
dissociation or electron-transfer dissociation (ETD) has recently
been established for CID-labile modiﬁcations such as
glycosylation and phosphorylation. The literature reports that
these methods have led to successful site-assignments for
phosphorylation (pArg and pLys) and glycosylation (N-
glycosylation and O-glycosylation) events16,43–47. CID was
recently used in an analysis of pCys in two potential
transcriptional regulators, SarA and MgrA, whose sequences are
thought to harbour phosphorylated Cys residues26. Although CID
fragmentation showed insufﬁcient sequence coverage with mainly
unphosphorylated fragment ions due to extensive neutral losses,
small intense intact fragments allowed to assign the phosphate
moiety to the Cys residue26.
This led to our ﬁrst attempts to fragment peptide 6a using
higher-energy collisional dissociation (HCD), a beam-type CID
fragmentation method. Unfortunately, complete neutral loss of
phosphate was observed and only unphosphorylated b- and
y-type fragments were detected (Supplementary Fig. 19). In
contrast, when using ETD with supplemental activation (SA), that
is, EThcD, we detected some c and z-type phosphorylated
fragment ions, which allow us to conﬁrm the phosphorylation at
Cys (Supplementary Fig. 20). The supplemental energy used in
EThcD improves the fragmentation of the charge-reduced
precursor ion48. Next, we synthesized a naturally occurring
pCys peptide, a tryptic pCys fragment peptide from the MgrA
regulator, which had previously been identiﬁed through CID
(EQLpCFSLYNAQR)26. This peptide (6b) was synthesized
following the above mentioned protocol, using phosphite 3d
and ﬁnal ultraviolet light exposure to deliver 6b in 5% overall
yield including SPPS after puriﬁcation by semi-preparative HPLC
(Supplementary Fig. 21). The fragmentation of peptide 6b using
EThcD yielded fragment ions covering the complete peptide
sequence (Fig. 3d). Importantly, the unphosphorylated fragment
c3 and the phosphorylated fragment c4 were identiﬁed, which
unambiguously conﬁrmed the phosphorylation at the Cys
residue. None of the fragments showed any indication of a
transfer to other potential phosphoacceptors.
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MS characterization of an endogenous pCys peptide. Following
our success at using EThcD to characterize a synthetic Cys-
phosphorylated peptide, we applied the method to identify a pCys
in a real biological sample. We chose the cytosolic IIBGlc domain
of the transmembrane subunit of the glucose speciﬁc transporter
IICBGlc from Escherichia coli (E. coli). IICBGlc is a member of the
PEP-dependent PTS and mediates the uptake into E. coli and
concomitant phosphorylation of glucose49. Several studies have
shown that glucose is phosphorylated after the phosphoryl moiety
has been transferred from PEP through a cascade involving three
pHis intermediates (EI, HPr, IIAGlc) and IIBGlc, which is a pCys
protein intermediate (Fig. 4a). Evidence of the pCys IICBGlc
intermediate has been demonstrated using NMR, isotopic
labelling strategies and stability studies21,22,24. CID-MS/MS has
also been used to acquire fragment ion spectra after enzymatic
digestion of IIBGlc but an unambiguous assignment of
phosphorylation to the Cys side-chain has been difﬁcult
because these experiments mainly generated unphosphorylated
y-type fragments with almost complete 80Da neutral losses23.
We ﬁrst overexpressed the four subunits required for the
phosphorylation event (EI, HPr, IIAGlc and IIBGlc) from the PTS.
Without purifying the protein subunits any further, we induced
in vitro phosphorylation by adding an excess of PEP to a cell
lysate containing the four subunits in addition to 10mM PBS
buffer (pH 7.5), sodium orthovanadate, dithiothreitol and MgCl2.
Afterwards, we applied a bottom-up proteomic approach using
SDS–polyacrylamide gel electrophoresis (PAGE) protein separa-
tion in combination with in-gel tryptic digestion (Fig. 4b), or
in-solution tryptic-digestion followed by a chromatographic
separation of peptides (Fig. 4c). The samples produced by both
methods were analysed through nLC-ESI-EThcD MS/MS
(Fig. 4b,c). The pCys tryptic peptide ENITNLDApCITR was
identiﬁed, together with the corresponding unphosphorylated
peptide (Fig. 5a,b and Supplementary Fig. 22). The MS/MS
spectra showed complete sequence coverage of the peptide,
permitting an unambiguous localization of the phosphorylation
site to the Cys residue (Fig. 5c). We observed no neutral losses or
phosphate rearrangements, another indication of the high-
stability of the phosphorothiolate bond in the gas-phase during
the EThcD process. The synthetic version (6c) of the endogenous
peptide was synthesized (Supplementary Fig. 23) and fragmented
by EThcD showing the same fragmentation pattern as observed
for the endogenous ENITNLDApCITR peptide (Supplementary
Figs 24 and 25).
Discussion
We have developed a novel chemoselective phosphorylation
strategy that enables us to incorporate phosphorylated Cys
residues on unprotected peptides in a stereochemically deﬁned
way. This chemical tool allowed us to synthesize pCys peptides
that could be used as probes for the establishment of an advanced
EThcD method that permits a reliable characterization and
assignment of this important, speciﬁc type of protein phosphor-
ylation. As a proof of principle, we used the EThcD method in
combination with a bottom-up proteomic approach to character-
ize an endogenous pCys peptide from E.coli. These results show
that the presented chemical and analytical tools are highly
valuable in accessing endogenous pCys peptides and thereby open
the possibility to identify new Cys phosphorylation sites from
biological samples.
Methods
General methods. All reagents, starting materials, amino acids and solvents were
purchased from commercial suppliers and used without further puriﬁcation if not
further mentioned. 1H and 31P-NMR spectra were recorded on a Bruker Ultra-
shield AV 600MHz at ambient temperature. The chemical shifts are reported in
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p.p.m. relatively to the residual solvent peak. UPLC-UV traces were obtained using
a Waters H-class instrument, equipped with a Quaternary Solvent Manager, a
Waters autosampler, a Waters Tunable UV detector connected to a 3,100 mass
detector using a Acquity UPLC-BEH C18 1.7 mM 2.1 50mm reversed-phase
column with a ﬂow rate of 0.6mlmin 1. The following solvent and gradients were
applied for all peptides if not further mentioned: method 1 (A¼H2Oþ 0.1% TFA,
B¼MeCNþ 0.1% TFA) 1% B 0–5min, 1–99% 5–15min, 99% B 15–17min.
Method 2 (A¼H2Oþ 0.1% TFA, B¼MeCNþ 0.1% TFA) 1% B 0–3min, 1–99%
3–8min, 99% B 8–10min. UPLC-UV chromatograms were recorded at 220 nm
(Supplementary Figs 26–39). Cys-containing, activated Ellman-disulﬁde and
phosphorothiolate ester peptides were puriﬁed on a Dionex 580 HPLC system
using a reversed phase Nucleodur C18 HTec column (10 250mm) at a ﬂow rate
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of 2mlmin 1 using a TFA gradient (0% B 0–5min; 0–50% B 5–60min; 50–100%
60–80min; 100% B 80–90min) in H2O/MeCN system (A¼H2Oþ 0.1% TFA,
B¼ 85% MeCNþ 15% Aþ 0.1% TFA) (Method A). Phosphorylated cysteine
peptides were puriﬁed on a Shimadzu HPLC system using a reversed phase
Nucleodur C18 HTec column (10 250mm) at a ﬂow rate of 3mlmin 1 using an
MeCN/H2O gradient system (0% B 0–5min; 0–40% B 5–55min; 40–100%
B 55–85min) in alkaline aqueous buffer (pH 8.2) as a mobile phase (A¼ 10mM
ammonium acetate in H2O, B¼MeCNþ 10% of sol. A) (Method B). Character-
ization of peptides were done with an Agilent 6,210 ToF liquid chromatography
(LC)/MS system and with an Orbitrap Fusion mass spectrometer (Thermo
Scientiﬁc) (Supplementary Figs 40–55).
SPPS. For the synthesis of all peptides in this study, standard Fmoc (9-ﬂuorenyl-
methoxycarbonyl)-based SPPS was used on Rink Amide or Wang resins. Peptides
were synthesized either manually or with a Tribute Peptide Synthesizer (Protein
Technologies, Inc) via standard Fmoc-based conditions with HOBt/HBTU/DIPEA
activation and piperidine Fmoc deprotection in DMF. Peptides were cleaved and
isolated by reversed-phase-HPLC and veriﬁed by electrospray ionization mass
spectroscopy (Supplementary Figs 40–43). For the speciﬁc procedures used for the
synthesis of the Cys-containing peptides 1a–e, see the Supplementary Methods.
Phosphite synthesis. Synthesis of phosphite esters 3b–3e has been described
previously9,10.
Synthesis of phosphorothiolate ester peptides. A stock solution of peptide 2a
(2.5mM) in DMF or in 25mM Tris-HCl buffer (pH 7.2) was prepared. All
phosphites employed (3a–e) were added in excess (5 eq.). Reactions in DMF and
Tris buffer were run until peptide 2a was fully or almost depleted (B16 h in DMF
and 3 h in Tris-HCl buffer) at room temperature. After the removing of solvents,
the crude reaction mixtures were diluted in a mixture of H2O/MeCN (8:2) and
injected in a UPLC-UV and -MS detector. Identity of the product was conﬁrmed
by high-resolution-MS and NMR (Supplementary Figs 48–52 and 56–59). For the
speciﬁc procedures used for the synthesis of the phosphorothiolate ester peptides
4 and 5, see the Supplementary Methods.
Epimerization studies. A stock solution (2.5mM) for each peptide tripeptide
(2b or 2c) in DMF or in 25mM Tris-HCl buffer (pH 7.2) was prepared. Phosphites
employed (3a, 3b, 3d) were added in excess (5 eq.). Reactions in DMF and Tris
buffer were run until peptide 2b or 2c was fully or almost depleted (B16 h in DMF
and 3 h in Tris buffer) at room temperature. After the removing of solvents, the
crude reaction mixtures were diluted in a mixture of H2O/MeCN (8:2) and injected
in a UPLC-UV and -MS detector. Retention times for each diastereoisomer
phosphorothiolate ester tripeptide were checked and compared (4f versus 4g,
4h versus 4i, and 4j versus 4k). Analytical co-injections by UPLC-UV (Method 1)
and -MS were performed for each pair of diastereoisomers. Identity
of the products was conﬁrmed by MS.
Ultraviolet-irradiation of o-nitrobenzyl-based phosphorothiolate ester
peptides. Tris-HCl buffered (20mM, pH 7.8) solution (500 ml) of peptide 4d
(1.8mM), 4l (0.96 mM), and 4m (0.95 mM) were irradiated at 295 nm with a
ultraviolet lamp for 5min and 4e (1.4mM) for 15min. The samples were injected
into the UPLC-UV and the identiﬁcation of the peaks was conﬁrmed by high-
resolution-MS and HCD fragmentation (Supplementary Figs 53–55 and 60).
Stability studies of phosphocysteine peptides. A solution stock of substrate 6a
(0.45 mM) in 10mM Tris-HCl buffer (pH 7.5) was prepared. Inosine (1mM) was
added as standard to monitor the decay of substrate 6a under different pH.
Aliquots (6ml) were taken every 2 h and analysed by UPLC-UV (220 nm).
Tandem MS (MS/MS) analysis. For LC–MS analysis, peptides were dissolved in
water (1 pM ml 1) and analysed by a reversed-phase capillary liquid chromato-
graphy system (Dionex Ultimate 3,000 NCS-3500RS Nano, Thermo Scientiﬁc)
connected to an Orbitrap Fusion mass spectrometer (Thermo Scientiﬁc). LC
separations were performed on an in-house packed 75 mm inner diameter PicoTip
column containing 25 cm of ReproSil-Pur C18AQ resin (3 mm, 120Å, Dr Maisch
GmbH Ammerbuch-Enttringen, Germany) at an eluent ﬂow rate of 300 nlmin 1
using a gradient of 2–50% B in 40min. Mobile phase A contained 0.1% FA in
water, and mobile phase B contained 0.1% FA in MeCN. Fourier transformed (FT)
survey scans were acquired in a range from 350 to 1,500m/z, with a resolution of
60,000, at an automatic gain control target of 100,000 and a max injection time of
50ms. In data-dependent mode monoisotopic precursor ions with charge states
between 2 and 5 were selected, preferential choosing higher charge states before
fragmentation. FTMS2 spectra were measured in the orbitrap with a resolution of
15,000, an automatic gain control target of 100,000 and a max injection time of
200ms. For HCD the normalized collision energy was set to 30%. EThcD spectra
were collected using calibrated charge-dependent ETD parameters and HCD SA
was enabled. For EThcD fragmentation the SA collision energy was set to 10%, 20%
or 30%, respectively. MS/MS spectra were manually veriﬁed and compared with the
theoretical fragment ions of the peptides considering all possible phosphorylation
sites.
Overexpression of EI, HPr, IIAGlc and IIBGlc. The EI construct was expressed
from the plasmid PMS EH2-EI in WA2127DHIC E. coli cells. Cells from glycerol-
stock, stored at  70 C, were picked and grown overnight in lysogeny broth (LB)
medium supplemented with ampicilin (100 mgml 1). One litre of freshly prepared
LB-ampicilin medium was then inoculated with 10ml overnight culture. The cells
were grown at 37 C in an orbital shaker to an OD550 of B0.8, induced with
isopropyl-b-D-thiogalactoside (IPTG; (100 mM ﬁnal concentration) and then
allowed to grow for another 5–6 h at 37 C. Cells from 2 l. LB-media were then
harvested by centrifugation (7,000g, 30min, 4 C) and stored at  20 C.
The HPr construct was expressed from the plasmid PtsH9 in WA2127DHIC
E. coli cells. Cells from glycerol-stock, stored at  70 C, were picked and grown
overnight in LB medium supplemented with ampicilin (50 mgml 1). One litre of
freshly prepared LB-ampicilin medium was then inoculated with 10ml overnight
culture. The cells were grown at 37 C in an orbital shaker to an OD550 of B0.8,
induced with IPTG (100 mM ﬁnal concentration) and then allowed to grow for
another 5–6 h at 37 C. Cells from 2 l. LB-media were then harvested by
centrifugation (7,000g, 30min, 4 C) and stored at  20 C.
The IIAGlc construct was expressed from the plasmid Crr-pMS470 D8 in
WA2127DHIC E. coli cells. Cells from glycerol-stock, stored at  70 C, were
picked and grown overnight in LB medium supplemented with ampicilin
(50 mgml 1). One litre of freshly prepared LB-ampicilin medium was then
inoculated with 10ml overnight culture. The cells were grown at 37 C in an orbital
shaker to an OD550 ofB0.8, induced with IPTG (100 mM ﬁnal concentration) and
then allowed to grow for another 5–6 h at 37 C. Cells from 2 l LB-media were then
harvested by centrifugation (7,000g, 30min, 4 C) and stored at  20 C.
The IIBGlc construct was expressed from the plasmid pet28H6 IIBGlc in
BW25113DacrB E. coli cells. Cells from glycerol-stock, stored at  70 C, were
picked and grown overnight in LB medium supplemented with kanamycine
(50 mgml 1). One litre of freshly prepared LB-kanamycine medium was then
inoculated with 10ml overnight culture. The cells were grown at 37 C in an orbital
shaker to an OD550 ofB0.8, induced with IPTG (100 mM ﬁnal concentration) and
then allowed to grow for another 3.5 h at 37 C. Cells from 2 l. LB-media were then
harvested by centrifugation (7,000g, 30min, 4 C) and stored at  20 C.
Cell lysate preparation. In all, 0.6 g for each cell pellet (2.4 g) was mixed together
and resuspended in 100ml 10mM PBS solution containing 1mM dithiothreitol,
1mM Na3VO4 and one complete EDTA-free protease inhibitor tablet (Roche
Diagnostics GmbH). The cells were lysed via sonication for 6min. After ultra-
centrifugation (18,000g for 25min, 4 C) the supernatant was collected, was ﬁltered
and aliquots were frozen in liquid nitrogen and stored at  80 C until further use
(48mgml 1 total protein concentration measured by Nanodrop).
In vitro phosphorylation. A volume of 150ml of 20mM PBS buffer containing
MgCl2 (1.3mM), dithiothreitol (5mM) and PEP (20.3mM) were added to 50 ml of
the cell lysate (see section ‘cell lysate preparation’, ﬁnal total protein concentration
was 12mgml 1 (Nanodrop)). After 1 h incubation at room temperature, a sample
(2.5 ml) of the mixture was either submitted for SDS–PAGE and further in-gel
trypsin digestion approach or alternatively used as a standard for in solution
trypsin digestion.
Proteomic identiﬁcation of an endogenous pCys peptide by an in-gel tryptic
digestion approach and LC–MS/MS. Following in vitro phosphorylation with
PEP, the cell lysate was analysed by SDS–PAGE gel electrophoresis. The gel band at
the expected shift (10 kDa) was cutted and a standard in-gel tryptic digestion
approach was performed50. Samples were re-suspended in 1% MeCN aqueous
solution and were submitted to nanoLC–MS/MS analysis using a C18 stationary
phase. Amino-acid sequence was conﬁrmed by HCD fragmentation
(Supplementary Fig. 61) (see Tandem MS analysis section).
Proteomic identiﬁcation of an endogenous pCys peptide by an ofﬂine two-
dimensional LC. Following in vitro phosphorylation with PEP, the cell lysate was
digested with 20mg of trypsin (sequencing grade, Promega) overnight. The digested
cell lysate was then submitted to a LC separation on a Acclaim Pep Map 100 C18
column (1.0mm 25 cm 5 mm) at an eluent ﬂow rate of 40ml min 1 using a
linear gradient of 1–50% B in 80min. Mobile phase A contained 0.1% TFA and 5%
MeCN in water, and mobile phase B contained 0.1% TFA and 20% water in MeCN.
Eluent was collected each 65 s and combined to 16 fractions. Fractions from
sequential elution section were pooled (for example, 1þ 17, 2þ 18, 3þ 19,y).
The samples were dried under vacuum, reconstituted in 6 ml of 1% MeCN, and
submitted to nanoLC–MS/MS analysis using a C18 stationary phase (see Tandem
MS analysis section).
Supplementary methods. Synthetic protocols and characterization of peptides,
UPLC-UV chromatogram traces, EThcD, HCD and NMR spectra are described
and shown in the Supplementary Information.
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Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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